Targeting Hypoxia-Inducible Factor 1 to Stimulate Tissue Vascularization

Journal of Investigative Medicine

Volumn 64, Issue 2, 2016, Pages 361-363

  Semenza, Gregg L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

angiogenesis; arteriogenesis; bronchiolitis obliterans; critical limb ischemia; desferrioxamine; dimethyloxalylglycine; prolyl hydroxylases

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ANGIOGENESIS; ANIMAL; DISEASE MODEL; GENE TARGETING; HUMAN; ISCHEMIA; METABOLISM; PATHOLOGY; VASCULAR REMODELING;

ANIMALS; DISEASE MODELS, ANIMAL; GENE TARGETING; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR REMODELING;

EID: 85002046686     PISSN: 10815589     EISSN: 17088267     Source Type: Journal    
DOI: 10.1097/jim-d-15-00088     Document Type: Article

References (25)

1. Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 1995;270:1230–7.
2. 2 tension. Proc Natl Acad Sci USA 1995;92:5510–4.
3. 2 tension. Am J Physiol 1996;271:C1172–80.
4. Prabhakar NR, Semenza GL. Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2. Physiol Rev 2012;92:967–1003.
5. Kaelin WG Jr, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 2008;30:393–402.
6. Wang GL, Semenza GL. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 1993;82:3610–5.
7. Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell 2012;148:399–408.
8. Forsythe JA, Jiang BH, Iyer NV, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996;16:4604–13.
9. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004;10:858–64.
10. Bosch-Marcé M, Okuyama H, Wesley JB, et al. Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ Res 2007;101:1310–8.
11. Simon MP, Tournaire R, Pouyssegur J. The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron by the central factors GATA-2, Ets-1. J Cell Physiol 2008;217:809–18.
12. Kelly BD, Hackett SF, Hirota K, et al. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 2003;93:1074–81.
13. Manalo DJ, Rowan A, Lavoie T, et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 2005;105:659–69.
14. Pipp F, Heil M, Issbrucker K, et al. VEGFR- 1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism. Circ Res 2003;92:378–85.
15. Clayton JA, Chalothorn D, Faber JE. Vascular endothelial growth factor-A specifies formation of native collaterals and regulates collateral growth in ischemia. Circ Res 2008;103:1027–36.
16. Rey S, Semenza GL. Hypoxia-inducible factor-1-dependent mechanisms of vascularization vascular remodelling. Cardiovasc Res 2010;86:236–42.
17. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007;45:S5–S67.
18. Rivard A, Fabre JE, Silver M, et al. Age-dependent impairment of angiogenesis. Circulation 1999;99:111–20.
19. Rivard A, Berthou-Soulie L, Principe N, et al. Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity. J Biol Chem 2000;275:29643–7.
20. Rey S, Lee K, Wang CJ, et al. Synergistic effect of HIF-1α gene therapy and HIF-1 -activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia. Proc Natl Acad Sci USA 2009;106:20399–404.
21. Rey S, Luo W, Shimoda LA, et al. Metabolic reprogramming by HIF-1 promotes the survival of bone marrow-derived angiogenic cells in ischemic tissue. Blood 2011;117:4988–98.
22. Luckraz H, Goddard M, McNeil K, et al. Microvascular changes in small airways predispose to obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant 2004;23:527–31.
23. Wilkes DS. Chronic lung allograft rejection and airway microvasculature: is HIF-1 the missing lhk? J Clin Invest 2011;121:2155–7.
24. Jiang X, Khan MA, Tian W, et al. Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection. J Clin Invest 2011;121:2336–49.
25. Jiang X, Malkovskiy AV, Tian W, et al. Promotion of airway anastomotic microvascular regeneration and alleviation of airway ischemia by deferoxamine nanoparticles. Biomaterials 2014;135:803–13.